CSRIX
Price
$54.78
Change
-$0.10 (-0.18%)
Updated
Aug 21 closing price
Net Assets
9.23B
PRRAX
Price
$31.91
Change
-$0.03 (-0.09%)
Updated
Aug 21 closing price
Net Assets
7B
Interact to see
Advertisement

CSRIX vs PRRAX

CSRIX vs PRRAX Comparison Chart in %
View a ticker or compare two or three
VS
CSRIX vs. PRRAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSRIX is a Hold and PRRAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSRIX has more cash in the bank: 9.23B vs. PRRAX (7B). CSRIX pays higher dividends than PRRAX: CSRIX (2.68) vs PRRAX (1.89). CSRIX was incepted earlier than PRRAX: CSRIX (27 years) vs PRRAX (21 years). PRRAX (1.19) is less costly to investors than CSRIX (0.76). CSRIX is a more actively managed with annual turnover of: 33.00 vs. PRRAX (18.50). PRRAX has a lower initial minimum investment than CSRIX: PRRAX (1000) vs CSRIX (1000000). CSRIX (15.19) and PRRAX (14.71) have marching annual gain over last year. CSRIX return over 5 years is better than : 15.94 vs. PRRAX (8.94).
CSRIXPRRAXCSRIX / PRRAX
Total Expense Ratio0.751.1963%
Annual Report Gross Expense Ratio0.761.1964%
Fund Existence27 years21 years-
Gain YTD16.07716.042100%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets9.23B7B132%
Annual Yield % from dividends2.681.89142%
Returns for 1 year15.1914.71103%
Returns for 3 years41.4235.18118%
Returns for 5 years15.948.94178%
Returns for 10 years47.1956.4684%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSHOX13.060.26
+2.03%
Morgan Stanley Inst Permanence C
RTNSX16.470.18
+1.10%
Russell Inv Tax-Managed Intl Eq S
GLCGX32.870.21
+0.64%
Goldman Sachs Large Cap Gr Insghts A
RMGSX12.760.06
+0.47%
Russell Inv Multi-Asset Strat S
ARIIX11.630.01
+0.09%
AB Global Real Estate Investment II I